Blueprint Medicines Corporation (BPMC)
USD 79.22
(-1.22%)
USD 79.22
(-1.22%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -486.27 Million USD | 11.47% |
| 2022 | -549.25 Million USD | 15.3% |
| 2021 | -648.46 Million USD | -314.62% |
| 2020 | 302.14 Million USD | 182.42% |
| 2019 | -366.58 Million USD | -48.4% |
| 2018 | -247.02 Million USD | -65.26% |
| 2017 | -149.47 Million USD | -103.07% |
| 2016 | -73.6 Million USD | -38.83% |
| 2015 | -53.02 Million USD | -33.11% |
| 2014 | -39.83 Million USD | -91.74% |
| 2013 | -20.77 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -48.97 Million USD | -13.77% |
| 2024 Q2 | -43.04 Million USD | 45.39% |
| 2024 Q1 | -78.82 Million USD | 25.01% |
| 2023 Q3 | -128.98 Million USD | -0.78% |
| 2023 Q4 | -105.11 Million USD | 18.51% |
| 2023 FY | -486.27 Million USD | 11.47% |
| 2023 Q1 | -135.37 Million USD | 13.67% |
| 2023 Q2 | -127.98 Million USD | 5.46% |
| 2022 Q2 | -157.63 Million USD | -48.99% |
| 2022 Q1 | -105.8 Million USD | 66.52% |
| 2022 FY | -549.25 Million USD | 15.3% |
| 2022 Q4 | -156.81 Million USD | -26.18% |
| 2022 Q3 | -124.27 Million USD | 21.16% |
| 2021 Q2 | -108.51 Million USD | -8.25% |
| 2021 Q4 | -316.05 Million USD | -169.91% |
| 2021 FY | -648.46 Million USD | -314.62% |
| 2021 Q1 | -100.23 Million USD | -16.6% |
| 2021 Q3 | -117.09 Million USD | -7.91% |
| 2020 Q4 | -85.96 Million USD | -113.57% |
| 2020 FY | 302.14 Million USD | 182.42% |
| 2020 Q1 | -113.65 Million USD | -63.82% |
| 2020 Q2 | -125.03 Million USD | -10.01% |
| 2020 Q3 | 633.36 Million USD | 606.54% |
| 2019 FY | -366.58 Million USD | -48.4% |
| 2019 Q1 | -90.07 Million USD | -8.34% |
| 2019 Q2 | -103.91 Million USD | -15.37% |
| 2019 Q3 | -97.96 Million USD | 5.73% |
| 2019 Q4 | -69.37 Million USD | 29.18% |
| 2018 Q2 | -29.46 Million USD | 49.98% |
| 2018 FY | -247.02 Million USD | -65.26% |
| 2018 Q4 | -83.14 Million USD | -10.11% |
| 2018 Q3 | -75.5 Million USD | -156.25% |
| 2018 Q1 | -58.91 Million USD | -17.6% |
| 2017 Q1 | -28.33 Million USD | -32.55% |
| 2017 FY | -149.47 Million USD | -103.07% |
| 2017 Q4 | -50.09 Million USD | -29.74% |
| 2017 Q3 | -38.61 Million USD | -12.85% |
| 2017 Q2 | -34.21 Million USD | -20.77% |
| 2016 Q1 | -15.42 Million USD | -0.03% |
| 2016 Q4 | -21.37 Million USD | -26.59% |
| 2016 Q3 | -16.88 Million USD | 10.65% |
| 2016 Q2 | -18.89 Million USD | -22.5% |
| 2016 FY | -73.6 Million USD | -38.83% |
| 2015 Q4 | -15.42 Million USD | -23.59% |
| 2015 FY | -53.02 Million USD | -33.11% |
| 2015 Q3 | -12.47 Million USD | -0.65% |
| 2015 Q2 | -12.39 Million USD | -9.22% |
| 2015 Q1 | -11.35 Million USD | 20.6% |
| 2014 Q1 | -6.95 Million USD | 0.0% |
| 2014 Q2 | -8.19 Million USD | -17.92% |
| 2014 Q3 | -10.28 Million USD | -25.49% |
| 2014 Q4 | -14.29 Million USD | -38.93% |
| 2014 FY | -39.83 Million USD | -91.74% |
| 2013 FY | -20.77 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -46.25 Million USD | -951.273% |
| Jaguar Health, Inc. | -34.29 Million USD | -1318.089% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -186.145% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -756.74% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -72.332% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 4171.99% |
| ContextLogic Inc. | -328 Million USD | -48.255% |
| MiMedx Group, Inc. | 37.11 Million USD | 1410.155% |
| MEI Pharma, Inc. | 14.54 Million USD | 3443.949% |
| AlloVir, Inc. | -181.33 Million USD | -168.171% |
| Novavax, Inc. | -566.51 Million USD | 14.163% |
| Aptorum Group Limited | -10.52 Million USD | -4520.942% |
| Ardelyx, Inc. | -63.27 Million USD | -668.501% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -137.206% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -17571.073% |
| Vaxcyte, Inc. | -468.04 Million USD | -3.896% |
| Precigen, Inc. | -88.92 Million USD | -446.852% |
| Pharming Group N.V. | -4.87 Million USD | -9865.624% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -190.641% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1534.215% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -2273.125% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -106.401% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -2404.192% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1900.596% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1900.596% |
| Bicycle Therapeutics plc | -189.94 Million USD | -156.008% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -77.47% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1559.365% |
| Acelyrin, Inc. | -422.06 Million USD | -15.214% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -1184.103% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -1211.993% |
| Senti Biosciences, Inc. | -92.72 Million USD | -424.418% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -323.686% |
| AbCellera Biologics Inc. | -237.2 Million USD | -105.001% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -1319.082% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -183.078% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -15278.779% |
| Chimerix, Inc. | -93.06 Million USD | -422.513% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1372.63% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -2672.547% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -978.762% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -859.259% |
| Elevation Oncology, Inc. | -45.44 Million USD | -970.034% |
| Alkermes plc | 414.12 Million USD | 217.424% |
| Fortress Biotech, Inc. | -142.34 Million USD | -241.626% |
| Fortress Biotech, Inc. | -142.34 Million USD | -241.626% |
| Agenus Inc. | -159.54 Million USD | -204.782% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -397.755% |
| Dyadic International, Inc. | -8.22 Million USD | -5808.778% |
| ImmuCell Corporation | -5.74 Million USD | -8359.819% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -40695.05% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -261.735% |
| Lantern Pharma Inc. | -17.87 Million USD | -2620.04% |
| Immix Biopharma, Inc. | -16.14 Million USD | -2912.661% |
| Incyte Corporation | 620.52 Million USD | 178.365% |
| IO Biotech, Inc. | -91.44 Million USD | -431.782% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -566.325% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -2320.518% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -815.321% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -276.994% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -5620.233% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -479.494% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -27.801% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 3.577% |
| NextCure, Inc. | -67.63 Million USD | -618.951% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -4503.588% |
| Onconetix, Inc. | -36.03 Million USD | -1249.473% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -1065.741% |
| Opthea Limited | -191.84 Million USD | -153.477% |
| PDS Biotechnology Corporation | -43.04 Million USD | -1029.688% |
| PureTech Health plc | -146.19 Million USD | -232.613% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -491.607% |
| Seer, Inc. | -103.46 Million USD | -370.001% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -3770968.342% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -1857.322% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -12235.644% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1562.031% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -615.155% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -1004.924% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -249.762% |
| ChromaDex Corporation | -5.59 Million USD | -8585.069% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -6949.536% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -318.991% |
| CRISPR Therapeutics AG | -222.53 Million USD | -118.514% |
| Precision BioSciences, Inc. | -43.73 Million USD | -1011.846% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -155.249% |
| Innoviva, Inc. | 176.7 Million USD | 375.185% |
| Summit Therapeutics Inc. | -89.73 Million USD | -441.897% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -639.484% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -576.014% |
| ESSA Pharma Inc. | -32.13 Million USD | -1413.274% |
| GlycoMimetics, Inc. | -39.27 Million USD | -1138.124% |
| GT Biopharma, Inc. | -13.57 Million USD | -3481.887% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -121.82% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 660.15% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -844.117% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -4793.282% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -87.275% |
| Aptose Biosciences Inc. | -52.35 Million USD | -828.789% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -3272.059% |
| Soligenix, Inc. | -7.69 Million USD | -6216.976% |
| Century Therapeutics, Inc. | -146.54 Million USD | -231.826% |
| Kura Oncology, Inc. | -165.8 Million USD | -193.284% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -420.316% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -5745.378% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -19494.993% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -7399.645% |
| Autolus Therapeutics plc | -195.02 Million USD | -149.337% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -474.408% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -560.146% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -2200.814% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -114.186% |
| GRI Bio, Inc. | -11.38 Million USD | -4170.458% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -10668.549% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -270.658% |
| IGM Biosciences, Inc. | -263.46 Million USD | -84.573% |
| INmune Bio, Inc. | -29.74 Million USD | -1535.039% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -339.612% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1177.145% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2943.157% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -2983.396% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -695.897% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -352.258% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -76.183% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -139.311% |
| Verastem, Inc. | -92.08 Million USD | -428.08% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -931.669% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -164.073% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -310.776% |
| Histogen Inc. | -10.64 Million USD | -4468.984% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -3042.957% |
| Surrozen, Inc. | -45.78 Million USD | -962.204% |
| Organovo Holdings, Inc. | -15.08 Million USD | -3123.366% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -9453.133% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -720.285% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -848.019% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -1823.564% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -6270.85% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -183.903% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -903.71% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -521.798% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -3094.824% |
| Apollomics, Inc. | -54.83 Million USD | -786.817% |
| Amarin Corporation plc | -67.58 Million USD | -619.472% |
| Mesoblast Limited | -58.79 Million USD | -727.086% |
| Turnstone Biologics Corp. | -59.03 Million USD | -723.752% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -193.77% |
| Synaptogenix, Inc. | -8.31 Million USD | -5748.996% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -3233.861% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -430.343% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -10048.815% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -5406.331% |
| Exelixis, Inc. | 170.88 Million USD | 384.564% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1170.914% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -213.6% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 5.965% |
| NLS Pharmaceutics AG | -11.8 Million USD | -4018.526% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -5946.788% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -1521.302% |
| Gritstone bio, Inc. | -154.63 Million USD | -214.47% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -606.172% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -2739.897% |
| Avid Bioservices, Inc. | -18.67 Million USD | -2503.475% |
| Insmed Incorporated | -709.62 Million USD | 31.474% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -2999.322% |
| MediWound Ltd. | -15.29 Million USD | -3080.36% |
| OmniAb, Inc. | -69.41 Million USD | -600.496% |
| Alector, Inc. | -151.74 Million USD | -220.467% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -350.327% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -832.494% |
| Zai Lab Limited | -366.57 Million USD | -32.655% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -53.508% |
| Aura Biosciences, Inc. | -84.99 Million USD | -472.151% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -98.077% |
| Immunic, Inc. | -99.22 Million USD | -390.085% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -239.679% |
| Veracyte, Inc. | -85.79 Million USD | -466.789% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -72.552% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3322.076% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -6959.825% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -2487.596% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 184.047% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -1810.49% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1353.227% |
| TG Therapeutics, Inc. | 20.63 Million USD | 2456.793% |
| Galecto, Inc. | -39.9 Million USD | -1118.587% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -1055.766% |
| Fortrea Holdings Inc. | 63.1 Million USD | 870.645% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -246.24% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1583.901% |
| XBiotech Inc. | -37.51 Million USD | -1196.393% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -606.172% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -624.489% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -350.649% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1794.192% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -812.477% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 14.57% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -519.524% |
| Vaxxinity, Inc. | -58.28 Million USD | -734.309% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -368.886% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -2085.207% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -462.716% |
| NexImmune, Inc. | -29.19 Million USD | -1565.761% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -8552.412% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -3234.918% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 112.015% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -1810.04% |
| Scopus BioPharma Inc. | -11.71 Million USD | -4050.936% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -282.708% |
| Ainos, Inc. | -13.2 Million USD | -3582.133% |
| Pluri Inc. | -22.15 Million USD | -2094.589% |
| Prothena Corporation plc | -191.03 Million USD | -154.547% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -252.278% |
| Celularity Inc. | -192.28 Million USD | -152.891% |
| Rallybio Corporation | -78.93 Million USD | -516.071% |
| Cue Biopharma, Inc. | -52.14 Million USD | -832.476% |
| MeiraGTx Holdings plc | -137.06 Million USD | -254.789% |
| Omeros Corporation | -164.53 Million USD | -195.555% |
| Humacyte, Inc. | -100.04 Million USD | -386.049% |
| Immunocore Holdings plc | -59.64 Million USD | -715.231% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -2520.168% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -1886.182% |
| CalciMedica, Inc. | -21.87 Million USD | -2122.981% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -551.322% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -269.835% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -183.883% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -48.754% |
| Pulmatrix, Inc. | -14.74 Million USD | -3199.03% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -1260.406% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -447.203% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 5.631% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -619.866% |
| Cytokinetics, Incorporated | -496.2 Million USD | 2.001% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -1312.816% |
| Nutriband Inc. | -4.87 Million USD | -9881.207% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -1014.982% |
| Vor Biopharma Inc. | -126.03 Million USD | -285.824% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 111.463% |
| Evogene Ltd. | -26.39 Million USD | -1742.586% |
| ProKidney Corp. | -151.52 Million USD | -220.928% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -653.509% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -6221.655% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 19.937% |
| CorMedix Inc. | -48.95 Million USD | -893.258% |
| BioLineRx Ltd. | -49.69 Million USD | -878.543% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -325.912% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -1177.256% |
| Atai Life Sciences N.V. | -125.47 Million USD | -287.561% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -495.641% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -497.326% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -95.301% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1481.903% |
| MediciNova, Inc. | -9.9 Million USD | -4811.757% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -284.795% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -6614.253% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1718.338% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -109.76% |
| Biomea Fusion, Inc. | -126.13 Million USD | -285.521% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -39.174% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1611.279% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -154.477% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -111.467% |
| Absci Corporation | -115.51 Million USD | -320.964% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1662.703% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -330.841% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -100.806% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -1829.977% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -133.794% |
| Allakos Inc. | -196.05 Million USD | -148.03% |
| Imunon, Inc. | -21.03 Million USD | -2212.254% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -339.418% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 553.27% |
| BioAtla, Inc. | -129.68 Million USD | -274.962% |
| NLS Pharmaceutics AG | -11.8 Million USD | -4018.526% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -2969.349% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -48.374% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -1064.512% |
| XOMA Corporation | -41.84 Million USD | -1062.008% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -362.078% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -300.244% |
| aTyr Pharma, Inc. | -54.91 Million USD | -785.444% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -456.209% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -181.296% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -91.109% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -2165.336% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -5820.997% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2793.473% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -5498886.207% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 244.05% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -7342.231% |
| UroGen Pharma Ltd. | -65.53 Million USD | -642.0% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -444.677% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -6595.253% |
| Orgenesis Inc. | -53.63 Million USD | -806.624% |
| Entera Bio Ltd. | -8.89 Million USD | -5369.317% |
| GH Research PLC | -41.22 Million USD | -1079.654% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -1791.54% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -485.502% |
| Xencor, Inc. | -138.63 Million USD | -250.751% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -9333.877% |
| Replimune Group, Inc. | -234.77 Million USD | -107.126% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -2162.688% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -3385.357% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -7342.231% |
| Portage Biotech Inc. | -18.25 Million USD | -2564.094% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -6614.253% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -363.293% |
| OncoCyte Corporation | -25.13 Million USD | -1834.584% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -4201.487% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -4144.343% |
| Purple Biotech Ltd. | 22.27 Million USD | 2283.454% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -6373.336% |
| scPharmaceuticals Inc. | -55.39 Million USD | -777.82% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -2473.208% |
| HilleVax, Inc. | -133.34 Million USD | -264.676% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -3935.829% |
| Tharimmune, Inc. | -9.45 Million USD | -5042.947% |
| Genprex, Inc. | -31.07 Million USD | -1464.821% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -158.391% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1449.788% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -63465.621% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -8827.561% |
| OKYO Pharma Limited | -15.74 Thousand USD | -3087425.945% |
| Savara Inc. | -60 Million USD | -710.367% |
| Curis, Inc. | -48.33 Million USD | -906.118% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1476.78% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -9220.508% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -6582.383% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -1684.503% |
| BeiGene, Ltd. | -1.2 Billion USD | 59.736% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -2338.787% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 0.186% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -419.238% |
| Erasca, Inc. | -141.52 Million USD | -243.598% |
| bluebird bio, Inc. | -244.26 Million USD | -99.08% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -10641.767% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 350.09% |
| DBV Technologies S.A. | -76.43 Million USD | -536.222% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -10641.767% |
| Moderna, Inc. | -4.23 Billion USD | 88.528% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1041.254% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -7545.865% |
| Molecular Templates, Inc. | -10.46 Million USD | -4546.255% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -623.228% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -29.074% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -239.316% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -835.274% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -214.657% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -133.641% |
| MacroGenics, Inc. | -168.24 Million USD | -189.031% |
| RenovoRx, Inc. | -11.39 Million USD | -4167.085% |
| Adicet Bio, Inc. | -152.03 Million USD | -219.839% |
| Prime Medicine, Inc. | -191.29 Million USD | -154.207% |
| Aditxt, Inc. | -26.06 Million USD | -1765.816% |
| Adagene Inc. | -23.71 Million USD | -1950.083% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6552.127% |
| Quantum-Si incorporated | -111.17 Million USD | -337.414% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1436.517% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3235.744% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 498.542% |
| SciSparc Ltd. | -5.77 Million USD | -8323.298% |
| Vericel Corporation | -6.46 Million USD | -7422.85% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -5517.372% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -2003.313% |
| Generation Bio Co. | -138.56 Million USD | -250.943% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -485.664% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -462.43% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -101.69% |
| Invivyd, Inc. | -207.78 Million USD | -134.031% |
| Relay Therapeutics, Inc. | -373 Million USD | -30.369% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -5085.017% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 2363.754% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4627.102% |
| 2seventy bio, Inc. | -216.7 Million USD | -124.398% |
| ADMA Biologics, Inc. | 21.63 Million USD | 2347.952% |
| Clene Inc. | -40.54 Million USD | -1099.499% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -1919.602% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -787.432% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1718.338% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -38.912% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -1223.85% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 3124.675% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -368.918% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -1330.142% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -185.578% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 28.939% |
| Evaxion Biotech A/S | -22.19 Million USD | -2090.733% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -490.271% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -117.94% |
| Trevena, Inc. | -35.28 Million USD | -1278.024% |
| Surrozen, Inc. | -45.78 Million USD | -962.204% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -508.264% |
| Cingulate Inc. | -22.75 Million USD | -2036.618% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 6590.617% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -988.672% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -5805.763% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -374.148% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -562.692% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -683.383% |
| Clearmind Medicine Inc. | -8.74 Million USD | -5462.951% |
| Kronos Bio, Inc. | -121.83 Million USD | -299.144% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -538.192% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -16479.594% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -382.288% |
| Statera Biopharma, Inc. | -98.34 Million USD | -394.466% |
| ImmunityBio, Inc. | -362.25 Million USD | -34.238% |
| Korro Bio, Inc. | -84.53 Million USD | -475.244% |
| Kineta, Inc. | -15.72 Million USD | -2992.775% |
| BioVie Inc. | -32.17 Million USD | -1411.135% |
| Codexis, Inc. | -68.06 Million USD | -614.388% |
| Celularity Inc. | -192.28 Million USD | -152.891% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -118.445% |
| Celcuity Inc. | -66.23 Million USD | -634.221% |
| Virax Biolabs Group Limited | -6.49 Million USD | -7385.246% |
| Cibus, Inc. | -318.88 Million USD | -52.494% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -1030.877% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -1336.819% |
| IN8bio, Inc. | -30.33 Million USD | -1502.917% |
| Kodiak Sciences Inc. | -277.32 Million USD | -75.348% |
| Annexon, Inc. | -143.72 Million USD | -238.343% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -292.821% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -652.215% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -1974.207% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -37.471% |
| Eyenovia, Inc. | -25.4 Million USD | -1813.991% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1589.819% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -8642.844% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -514.506% |
| Arcellx, Inc. | -89.88 Million USD | -441.029% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -970.812% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -254.411% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1463.139% |
| Moolec Science SA | -6.65 Million USD | -7208.254% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -695.376% |
| Geron Corporation | -193.94 Million USD | -150.731% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -1024.262% |
| Royalty Pharma plc | 1.49 Billion USD | 132.589% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -196.218% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -5113.165% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -2120.984% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -184.444% |
| Humacyte, Inc. | -100.04 Million USD | -386.049% |
| Structure Therapeutics Inc. | -102.77 Million USD | -373.147% |
| 89bio, Inc. | -151.2 Million USD | -221.603% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -506.845% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -3244.409% |
| Genelux Corporation | -24.16 Million USD | -1912.319% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1333.473% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -183.131% |
| Notable Labs, Ltd. | -14.65 Million USD | -3217.712% |
| Liquidia Corporation | -73.38 Million USD | -562.647% |
| Mustang Bio, Inc. | -50.72 Million USD | -858.635% |
| Immunovant, Inc. | -282.7 Million USD | -72.006% |
| Quantum-Si incorporated | -111.17 Million USD | -337.414% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -522.61% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -2186.533% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -376.686% |
| Acasti Pharma Inc. | -11.31 Million USD | -4198.771% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -2021.525% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2943.157% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -127.175% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -13153.406% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2961.041% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1567.788% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -1075.036% |
| PepGen Inc. | -84.76 Million USD | -473.67% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1541.109% |
| United Therapeutics Corporation | 1.18 Billion USD | 141.039% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2023.759% |
| Solid Biosciences Inc. | -104.31 Million USD | -366.162% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1382.185% |
| Immuneering Corporation | -58.41 Million USD | -732.482% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -9453.133% |
| Silo Pharma, Inc. | -3.85 Million USD | -12512.253% |
| Belite Bio, Inc | -31.66 Million USD | -1435.547% |
| XOMA Corporation | -41.84 Million USD | -1062.008% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -620.197% |
| Bionomics Limited | -17.89 Billion USD | 97.282% |
| Apogee Therapeutics, Inc. | -93 Million USD | -422.862% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1462.884% |
| uniQure N.V. | -282.87 Million USD | -71.908% |
| Cassava Sciences, Inc. | -105.95 Million USD | -358.938% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6552.127% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -275.492% |
| Forte Biosciences, Inc. | -32.48 Million USD | -1396.882% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -5752.586% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1554.285% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -8642.844% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3322.076% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -5370.548% |
| Altimmune, Inc. | -95.92 Million USD | -406.913% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -561.655% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1462.884% |
| Compugen Ltd. | -12.99 Million USD | -3642.896% |
| Peak Bio, Inc. | -1356.23 USD | -35854954.084% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -880.318% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2062.192% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -100.69% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1534.764% |
| Zura Bio Limited | -62.63 Million USD | -676.329% |
| PolyPid Ltd. | -22.86 Million USD | -2026.545% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -2887.694% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1534.764% |
| Instil Bio, Inc. | -159.16 Million USD | -205.51% |
| argenx SE | -425.04 Million USD | -14.405% |
| Immunome, Inc. | -109.53 Million USD | -343.967% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -865.544% |
| Verona Pharma plc | -67.83 Million USD | -616.896% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -1765.99% |
| Shattuck Labs, Inc. | -91.95 Million USD | -428.809% |
| CervoMed Inc. | -7.81 Million USD | -6124.031% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -565.131% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -3550.454% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -909.418% |
| Moolec Science SA | -6.65 Million USD | -7208.254% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -2856.372% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -259.601% |
| AnaptysBio, Inc. | -164.41 Million USD | -195.769% |
| Design Therapeutics, Inc. | -78.19 Million USD | -521.917% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -458.676% |
| NeurAxis, Inc. | -6.66 Million USD | -7196.532% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -1100.714% |
| Lumos Pharma, Inc. | -36.61 Million USD | -1228.118% |
| Achilles Therapeutics plc | -75.25 Million USD | -546.172% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -1765.99% |
| 180 Life Sciences Corp. | -13.47 Million USD | -3508.065% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 9530.715% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -16479.594% |
| Nutriband Inc. | -4.87 Million USD | -9881.207% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -338.957% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -776.981% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -856.56% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -635.68% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -798.465% |
| Palisade Bio, Inc. | -13.07 Million USD | -3620.559% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -970.882% |
| Beam Therapeutics Inc. | -176.48 Million USD | -175.534% |
| Neurogene Inc. | -55.58 Million USD | -774.866% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -345.496% |
| AEON Biopharma, Inc. | -48.42 Million USD | -904.103% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -402.82% |
| Sesen Bio, Inc. | -25.9 Million USD | -1776.865% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -482.165% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -3763.359% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | -5.584% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -571.292% |
| Athira Pharma, Inc. | -125.46 Million USD | -287.577% |
| Vaccinex, Inc. | -22.88 Million USD | -2024.872% |
| HCW Biologics Inc. | -25.71 Million USD | -1790.866% |
| XOMA Corporation | -41.84 Million USD | -1062.008% |
| Nektar Therapeutics | -137.42 Million USD | -253.849% |
| Arvinas, Inc. | -401.5 Million USD | -21.115% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -5498886.207% |
| Merus N.V. | -156.54 Million USD | -210.627% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -385.011% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -1304.613% |
| Rezolute, Inc. | -70.42 Million USD | -590.509% |
| Clene Inc. | -40.54 Million USD | -1099.499% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -2869.001% |
| BeyondSpring Inc. | -23.11 Million USD | -2003.82% |
| Synlogic, Inc. | -55.16 Million USD | -781.559% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -2612.237% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -4392.581% |
| Peak Bio, Inc. | -1356.23 USD | -35854954.084% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -1100.595% |
| Krystal Biotech, Inc. | -109.72 Million USD | -343.17% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -275.388% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -41.766% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -10146.14% |
| MannKind Corporation | 8.67 Million USD | 5703.561% |
| Ikena Oncology, Inc. | -75.41 Million USD | -544.784% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -4940.707% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -623.304% |
| Gossamer Bio, Inc. | -183.75 Million USD | -164.628% |
| CohBar, Inc. | -12.38 Million USD | -3825.293% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -858.672% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1662.703% |
| Legend Biotech Corporation | -439.48 Million USD | -10.647% |
| Mural Oncology plc | -194.63 Million USD | -149.837% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -624.241% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2911.885% |
| Disc Medicine, Inc. | -91.12 Million USD | -433.637% |
| Champions Oncology, Inc. | -7.35 Million USD | -6510.617% |
| REGENXBIO Inc. | -268.12 Million USD | -81.36% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -4436.933% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -772.152% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -1148.124% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -325.227% |
| Vaxart, Inc. | -83.34 Million USD | -483.437% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -5607.471% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -1036.318% |
| Cellectis S.A. | -106.62 Million USD | -356.059% |
| Longeveron Inc. | -21.02 Million USD | -2212.411% |
| Repare Therapeutics Inc. | -116.22 Million USD | -318.396% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -81.566% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -542.841% |
| Revolution Medicines, Inc. | -487.18 Million USD | 0.186% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -7210.238% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -1006.332% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -551.933% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -598.323% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -4316.284% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 111.289% |
| Denali Therapeutics Inc. | -196.69 Million USD | -147.219% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -5517.372% |
| Veru Inc. | -93.78 Million USD | -418.517% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -1984.431% |
| Cingulate Inc. | -22.75 Million USD | -2036.618% |
| Passage Bio, Inc. | -108.38 Million USD | -348.641% |
| Context Therapeutics Inc. | -25.07 Million USD | -1839.475% |
| Exicure, Inc. | -14.99 Million USD | -3142.711% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -135.983% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -1097.786% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -4904.427% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -163.769% |
| Nuvalent, Inc. | -149.49 Million USD | -225.286% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -5818.292% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -448.035% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -2240.796% |
| OmniAb, Inc. | -69.41 Million USD | -600.496% |
| Anew Medical, Inc. | -1.3 Million USD | -37281.769% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -3707.666% |
| Lipocine Inc. | -17.93 Million USD | -2611.941% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -609.759% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -538.561% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1177.145% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -1130.24% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -2072.431% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 16.137% |
| Ocugen, Inc. | -65.53 Million USD | -642.056% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -418.054% |
| Q32 Bio Inc. | -92.1 Million USD | -427.977% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -2168.189% |
| Alumis Inc. Common Stock | -158.17 Million USD | -207.432% |
| Equillium, Inc. | -14.52 Million USD | -3248.554% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -679.215% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -6052.797% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2477.653% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -935.712% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -348.322% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -3962.459% |
| Dominari Holdings Inc. | -21.79 Million USD | -2131.038% |
| Edesa Biotech, Inc. | -9.22 Million USD | -5172.577% |
| vTv Therapeutics Inc. | -25.5 Million USD | -1806.819% |
| Bio-Techne Corporation | 206.68 Million USD | 335.273% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -24.213% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 353.23% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -267.62% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -1166.643% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -221.822% |
| Nkarta, Inc. | -131.65 Million USD | -269.371% |
| BioCardia, Inc. | -11.64 Million USD | -4076.202% |
| Iterum Therapeutics plc | -47.46 Million USD | -924.431% |